Summary

This report contains market size and forecasts of Sterile Active Pharmaceutical Ingredients in China, including the following market information:
China Sterile Active Pharmaceutical Ingredients Market Revenue, 2016-2021, 2022-2027, ($ millions)
China Sterile Active Pharmaceutical Ingredients Market Sales, 2016-2021, 2022-2027, (Kiloton)
China top five Sterile Active Pharmaceutical Ingredients companies in 2020 (%)
The global Sterile Active Pharmaceutical Ingredients market size is expected to growth from US$ XX million in 2020 to US$ XX million by 2027; it is expected to grow at a CAGR of XX% during 2021-2027.
The China Sterile Active Pharmaceutical Ingredients market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.
QYResearch has surveyed the Sterile Active Pharmaceutical Ingredients manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
China Sterile Active Pharmaceutical Ingredients Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (Kiloton)
China Sterile Active Pharmaceutical Ingredients Market Segment Percentages, By Type, 2020 (%)
Aqueous
Non-aqueous Liquid
Dry Powder
Others

China Sterile Active Pharmaceutical Ingredients Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (Kiloton)
China Sterile Active Pharmaceutical Ingredients Market Segment Percentages, By Application, 2020 (%)
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sterile Active Pharmaceutical Ingredients revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies Sterile Active Pharmaceutical Ingredients revenues share in China market, 2020 (%)
Key companies Sterile Active Pharmaceutical Ingredients sales in China market, 2016-2021 (Estimated), (Kiloton)
Key companies Sterile Active Pharmaceutical Ingredients sales share in China market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Aurobindo Pharma
Teva Pharmaceutical Industries
Corden Pharma
Dalton Pharma Services
Pfizer
Sun Pharmaceutical Industries
Lonza Group
Albany Molecular Research
Sanofi
Dr. Reddy’s Laboratories

ページTOPに戻る

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Sterile Active Pharmaceutical Ingredients Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Sterile Active Pharmaceutical Ingredients Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year

2 China Sterile Active Pharmaceutical Ingredients Overall Market Size
2.1 China Sterile Active Pharmaceutical Ingredients Market Size: 2021 VS 2027
2.2 China Sterile Active Pharmaceutical Ingredients Revenue, Prospects & Forecasts: 2016-2027
2.3 China Sterile Active Pharmaceutical Ingredients Sales: 2016-2027

3 Company Landscape
3.1 Top Sterile Active Pharmaceutical Ingredients Players in China Market
3.2 Top China Sterile Active Pharmaceutical Ingredients Companies Ranked by Revenue
3.3 China Sterile Active Pharmaceutical Ingredients Revenue by Companies
3.4 China Sterile Active Pharmaceutical Ingredients Sales by Companies
3.5 China Sterile Active Pharmaceutical Ingredients Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Sterile Active Pharmaceutical Ingredients Companies in China Market, by Revenue in 2020
3.7 Manufacturers Sterile Active Pharmaceutical Ingredients Product Type
3.8 Tier 1, Tier 2 and Tier 3 Sterile Active Pharmaceutical Ingredients Players in China Market
3.8.1 List of Tier 1 Sterile Active Pharmaceutical Ingredients Companies in China
3.8.2 List of Tier 2 and Tier 3 Sterile Active Pharmaceutical Ingredients Companies in China

4 Sights by Type
4.1 Overview
4.1.1 By Type - China Sterile Active Pharmaceutical Ingredients Market Size Markets, 2021 & 2027
4.1.2 Aqueous
4.1.3 Non-aqueous Liquid
4.1.4 Dry Powder
4.1.5 Others
4.2 By Type - China Sterile Active Pharmaceutical Ingredients Revenue & Forecasts
4.2.1 By Type - China Sterile Active Pharmaceutical Ingredients Revenue, 2016-2021
4.2.2 By Type - China Sterile Active Pharmaceutical Ingredients Revenue, 2022-2027
4.2.3 By Type - China Sterile Active Pharmaceutical Ingredients Revenue Market Share, 2016-2027
4.3 By Type - China Sterile Active Pharmaceutical Ingredients Sales & Forecasts
4.3.1 By Type - China Sterile Active Pharmaceutical Ingredients Sales, 2016-2021
4.3.2 By Type - China Sterile Active Pharmaceutical Ingredients Sales, 2022-2027
4.3.3 By Type - China Sterile Active Pharmaceutical Ingredients Sales Market Share, 2016-2027
4.4 By Type - China Sterile Active Pharmaceutical Ingredients Price (Manufacturers Selling Prices), 2016-2027

5 Sights by Application
5.1 Overview
5.1.1 By Application - China Sterile Active Pharmaceutical Ingredients Market Size, 2021 & 2027
5.1.2 CNS
5.1.3 Cardiovascular
5.1.4 Genitourinary/Hormonal Drugs
5.1.5 Respiratory
5.1.6 Rheumatology
5.1.7 Diabetes
5.1.8 Oncology
5.1.9 Others
5.2 By Application - China Sterile Active Pharmaceutical Ingredients Revenue & Forecasts
5.2.1 By Application - China Sterile Active Pharmaceutical Ingredients Revenue, 2016-2021
5.2.2 By Application - China Sterile Active Pharmaceutical Ingredients Revenue, 2022-2027
5.2.3 By Application - China Sterile Active Pharmaceutical Ingredients Revenue Market Share, 2016-2027
5.3 By Application - China Sterile Active Pharmaceutical Ingredients Sales & Forecasts
5.3.1 By Application - China Sterile Active Pharmaceutical Ingredients Sales, 2016-2021
5.3.2 By Application - China Sterile Active Pharmaceutical Ingredients Sales, 2022-2027
5.3.3 By Application - China Sterile Active Pharmaceutical Ingredients Sales Market Share, 2016-2027
5.4 By Application - China Sterile Active Pharmaceutical Ingredients Price (Manufacturers Selling Prices), 2016-2027

6 Manufacturers & Brands Profiles
6.1 Aurobindo Pharma
6.1.1 Aurobindo Pharma Corporation Information
6.1.2 Aurobindo Pharma Overview
6.1.3 Aurobindo Pharma Sterile Active Pharmaceutical Ingredients Sales and Revenue in China Market (2016-2021)
6.1.4 Aurobindo Pharma Sterile Active Pharmaceutical Ingredients Product Description
6.1.5 Aurobindo Pharma Recent Developments
6.2 Teva Pharmaceutical Industries
6.2.1 Teva Pharmaceutical Industries Corporation Information
6.2.2 Teva Pharmaceutical Industries Overview
6.2.3 Teva Pharmaceutical Industries Sterile Active Pharmaceutical Ingredients Sales and Revenue in China Market (2016-2021)
6.2.4 Teva Pharmaceutical Industries Sterile Active Pharmaceutical Ingredients Product Description
6.2.5 Teva Pharmaceutical Industries Recent Developments
6.3 Corden Pharma
6.3.1 Corden Pharma Corporation Information
6.3.2 Corden Pharma Overview
6.3.3 Corden Pharma Sterile Active Pharmaceutical Ingredients Sales and Revenue in China Market (2016-2021)
6.3.4 Corden Pharma Sterile Active Pharmaceutical Ingredients Product Description
6.3.5 Corden Pharma Recent Developments
6.4 Dalton Pharma Services
6.4.1 Dalton Pharma Services Corporation Information
6.4.2 Dalton Pharma Services Overview
6.4.3 Dalton Pharma Services Sterile Active Pharmaceutical Ingredients Sales and Revenue in China Market (2016-2021)
6.4.4 Dalton Pharma Services Sterile Active Pharmaceutical Ingredients Product Description
6.4.5 Dalton Pharma Services Recent Developments
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Overview
6.5.3 Pfizer Sterile Active Pharmaceutical Ingredients Sales and Revenue in China Market (2016-2021)
6.5.4 Pfizer Sterile Active Pharmaceutical Ingredients Product Description
6.5.5 Pfizer Recent Developments
6.6 Sun Pharmaceutical Industries
6.6.1 Sun Pharmaceutical Industries Corporation Information
6.6.2 Sun Pharmaceutical Industries Overview
6.6.3 Sun Pharmaceutical Industries Sterile Active Pharmaceutical Ingredients Sales and Revenue in China Market (2016-2021)
6.6.4 Sun Pharmaceutical Industries Sterile Active Pharmaceutical Ingredients Product Description
6.6.5 Sun Pharmaceutical Industries Recent Developments
6.7 Lonza Group
6.7.1 Lonza Group Corporation Information
6.7.2 Lonza Group Overview
6.7.3 Lonza Group Sterile Active Pharmaceutical Ingredients Sales and Revenue in China Market (2016-2021)
6.7.4 Lonza Group Sterile Active Pharmaceutical Ingredients Product Description
6.7.5 Lonza Group Recent Developments
6.8 Albany Molecular Research
6.8.1 Albany Molecular Research Corporation Information
6.8.2 Albany Molecular Research Overview
6.8.3 Albany Molecular Research Sterile Active Pharmaceutical Ingredients Sales and Revenue in China Market (2016-2021)
6.8.4 Albany Molecular Research Sterile Active Pharmaceutical Ingredients Product Description
6.8.5 Albany Molecular Research Recent Developments
6.9 Sanofi
6.9.1 Sanofi Corporation Information
6.9.2 Sanofi Overview
6.9.3 Sanofi Sterile Active Pharmaceutical Ingredients Sales and Revenue in China Market (2016-2021)
6.9.4 Sanofi Sterile Active Pharmaceutical Ingredients Product Description
6.9.5 Sanofi Recent Developments
6.10 Dr. Reddy’s Laboratories
6.10.1 Dr. Reddy’s Laboratories Corporation Information
6.10.2 Dr. Reddy’s Laboratories Overview
6.10.3 Dr. Reddy’s Laboratories Sterile Active Pharmaceutical Ingredients Sales and Revenue in China Market (2016-2021)
6.10.4 Dr. Reddy’s Laboratories Sterile Active Pharmaceutical Ingredients Product Description
6.10.5 Dr. Reddy’s Laboratories Recent Developments

7 China Sterile Active Pharmaceutical Ingredients Production Capacity, Analysis
7.1 China Sterile Active Pharmaceutical Ingredients Production Capacity, 2016-2027
7.2 Sterile Active Pharmaceutical Ingredients Production Capacity of Key Manufacturers in China Market

8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints

9 Sterile Active Pharmaceutical Ingredients Supply Chain Analysis
9.1 Sterile Active Pharmaceutical Ingredients Industry Value Chain
9.2 Sterile Active Pharmaceutical Ingredients Upstream Market
9.3 Sterile Active Pharmaceutical Ingredients Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Sterile Active Pharmaceutical Ingredients Distributors and Sales Agents in China Market

10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer